azacitidine,magrolimab,elranatamab
pfizer
['magnetismm-3', 'mmsm', 'p949', 'multiplemyeloma']
#haematology oncology expert dr presents the initial safety results for magnetismm-3 trial in a poster at #eha2022. abstract p949 available from today until 15 june read more here: #mmsm #hematology #meded #multiplemyeloma 
Independent, international experts in hematology and oncology, creating educational programmes on #lymsm and #mmsm.

#MedEd #oncology #hematology